Expertos Invitados





ASPERGILOSIS BRONCOPULMONAR ALERGICA: PUESTA AL DIA Y PROTOCOLO DE ASISTENCIA UNIDAD FQ HOSPITAL INFANTIL "NIÑO JESUS" DE MADRID - ESPAÑA

(especial para SIIC © Derechos reservados)
La inflamación y degeneración de la pared bronquial, con producción de bronquiectasias y fibrosis a largo plazo, son características de esta enfermedad. Es una complicación que aparece con frecuencia en pacientes asmáticos.
Autor:
Antonio Salcedo posadas
Columnista Experto de SIIC
Artículos publicados por Antonio Salcedo posadas
Recepción del artículo
3 de Junio, 2002 		Primera edición
11 de Julio, 2002 		Segunda edición, ampliada y corregida
7 de Junio, 2021

ASPERGILOSIS BRONCOPULMONAR ALERGICA: PUESTA AL DIA Y PROTOCOLO DE ASISTENCIA UNIDAD FQ HOSPITAL INFANTIL "NIÑO JESUS" DE MADRID - ESPAÑA


Artículo completo
(castellano)
Extensión:  +/-7.41 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Neumonología
Relacionadas: Diagnóstico por Laboratorio, Epidemiología, Farmacología, Infectología



Comprar este artículo
Extensión: 7.41 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Bibliografía del artículo
  1. Kauffman HF and Tomee JFC. Inflamatory cells and airway defense against Aspergillus fumigatus. Immunology and Allergy Clinics of North America 1998; 18 (3): 619-40.
  2. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952; 7: 317-33.
  3. Mearns M, Young W, Batten J. Transient pulmonary infiltrations in cystic fibrosis due to allergic aspergillosis. Thorax 1965; 20: 385-92.
  4. Rosenberg M, Patterson R, Minitzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunological criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405-14.
  5. Laufer P, Fink JN, Bruns WT, Unger GF, Kalbfleisch JH, Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73:44-8.
  6. Greenberger PA, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 1986; 56: 444-52.
  7. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiological Registry of Cystic Fibrosis. Eur Resp J 2000; 16: 464-71.
  8. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patien characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiological Study of Cystic Fibrosis. Chest 1999; 116: 639-46.
  9. Miller PW, Hamosh A, Macek M, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Allergic Bronchopulmonary Aspergillosis. Am J Hum Genet 1996; 59: 45-51.
  10. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier JF, Vandenplas O. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001; 119: 762-7.
  11. Warner JO, Taylor BW, Norman AP, Soothill JF. Association of cystic fibrosis with allergy. Arch Dis Child 1976; 51: 507-11.
  12. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, Slavin RG, Bellone CJ. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000; 106: 723-9.
  13. Chauhan B, Knutsen AP, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97: 2324-31.
  14. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998; 131 (3): 194-6.
  15. Murali PS, Kurup VP, Bansal NK, Fink JN, Greenberger PA. IgE down regulation and cytokine induction by Aspergillus in human allergic bronchopulmonary aspergillosis. J Lab Clin Med 1998; 131: 228-35.
  16. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999; 50: 303-16.
  17. Khan S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 2000; 123: 319-26.
  18. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatric Pulmonol 1999; 27: 130-3.
  19. Knutsen AP, Chauhan B, Slavin RG. Cell-mediated immunity in Allergic Bronchopulmonary Aspergillosis. Immunology and Allergy Clinics of North America 1998; 18 (3): 575-99.
  20. Wark PA, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 2001; 6: 1-7.
  21. Malo JL, Hawkins R, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 1 Clinical and physiological findings. Thorax 1977; 32: 254-61.
  22. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Resp Dis 1979;120:863-73.
  23. Feanny S, Forsyth S, Corey M, Levison H, Zimmerman B. Allergic bronchopulmonary Aspergillosis in cystic fibrosis: a secretory immune response to a colonizing organism. Ann Allergy 1988; 60:64-8.
  24. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Role of atopy and response to Itraconazole. Chest 1999; 115: 364-70.
  25. Zhaoming W, Lockey RF. A review of allergic bronchopulmonary aspergillosis. Invest Allergol Clin Immunol 1996; 6 (3): 144-51.
  26. Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 1994; 49: 1002-5.
  27. Salcedo A. Exacerbación respiratoria y aspergilosis broncopulmonar alérgica en Fibrosis Quística. Enferm Infecc Microbiol Clin 2000; 18: 301-3.
  28. Salcedo A. Aspergilosis broncopulmonar alérgica. An Esp Ped. Supl 133: 16-21. Novbre 1999.
  29. Skov M, Koch C, Reimert CM, Poulsen LK. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 2000; 55: 50-8.
  30. Warren CPW, Tai E, Batten JC, Hutchcroft BJ, Pepys J. Cystic fibrosis-immunological reactions to A. fumigatus and common alergens. Clin Allergy 1975;1:1-12.
  31. Zeaske R, Bruns WT, Fink JN, Greenberger PA, Colby H, Liotta JUL, Roberts M. Immune responses to Aspergillus in cystic fibrosis. J Allergy Clin Inmunol 1988; 82:73-7.
  32. Nikolaizik WH, Moser M, Crameri R, Little S, Warner JO, Blaser K, Schöni MH. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995; 152: 634-9
  33. El-Dhar JM, Fink R, Selden R, Arruda LK, Platts-Mills TAE, Heymann PW. Development of immnune responses to Aspergillus at an early age in children with cystic fibrosis. Am J Resp Crit Care Med 1994; 150: 1513-18.
  34. Cystic Fibrosis Foundation. Patient Registry 1996 Annual Data Report. Bethesda, MD: Cystic fibrosis Foundation, August 1997.
  35. Paty E, Kraminel S, De Montalembert M, Lenoir G, Paupe J, De Blic J, Scheinmann P. Mucoviscidose et aspergillose bronchopulmonaire Arch Fr Ped 1991; 48: 675-7.
  36. Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol 1991; 88:390-4.
  37. Nikolaizik WH, Brueton MJ, Warner JO. Aspergillus allergy and allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Allergy Immunol 1991; 2:83-6.
  38. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105:32-6.
  39. Máiz L, Cuevas M, Quirce S, Pacheco A, Escobar H. Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis. J Allergy Clin Immunol 1997; 100: 431-2.
  40. Mearns M, Longbottom J, Batten J. Precipitating antibodies to Aspergillus fumigatus in cystic fibrosis. Lancet 1967; 1:538-9.
  41. Schwartz RH, Johnstone DE, Holschaw DS, Dooley RR. Serum precipitins to Aspergillus fumigatus in cystic fibrosis. Am J Dis Child 1970; 120:432-3.
  42. Hutcheson PS, Knutsen AP, Rejent AJ, Slavin RG. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996; 110: 363-6.
  43. Wojnarowski C, Eichler I, Gartner C, Götz M, Renner S, Koller DY, Frischer T. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Resp Crit Care Med 1997; 155: 1902-7.
  44. Banerjee B, Greenberger PA, Fink JN, Kurup VP. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun 1998; Vol 66 No 11: 5175-82
  45. Hemmann S, Nikolaizik WH, Schöni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28: 1155-60.
  46. Banerjee B, Kurup VP. Molecular biology of Aspergillus allergens. Immunology and Allergy Clinics of North America 1998; 18 (3): 601-18.
  47. Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. AM J Resp Crit Care Med 2002; 165: 916-21.
  48. Nikolaizik WH, Crameri R, Blaser K, Schöni MH. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int Arch Allergy Immunol 1996; 111:403-8.
  49. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specific IgE subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54: 44-50
  50. Little SA, Warner JO. Improved diagnosis of allergic bronchopulmonary aspergillosis with gp66 (formerly antigen 7) of Aspergillus fumigatus for specific IgE detection. J Allergy Clin Immunol 1996; 98 (1): 55-63.
  51. Sarma PU, Banerjee B, Bir N, Kurup VP. Immunodiagnosis of allergic bronchopulmonary aspergillosis. Immunology and Allergy Clinics of North America 1998; 18 (3): 525-47.
  52. Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG. Serum anti-Aspergillus fumigatus Antibodies by immunoblot and ELISA in cyistic fibrosis with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994; 93: 926-3.
  53. Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, et al. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. Lancet 2000; 342: 851-9.
  54. Germaud P. Allergic bronchopulmonary aspergillosis treated with Itraconazol (letter). Chest 1995; 107 (3): 883.
  55. Elphick H, Southern K. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. (Cochrane Review). In: The Cochrane Lybrary, Issue 4, 2000. Oxford: Update Software.
  56. Wark P, Wilson AJ, Gibson PG. Azoles for allergic bronchopulmonary aspergillosis (Cochrane Review). In: The Cochrane Lybrary, Issue 4, 2000. Oxford: Update Software.
  57. Sermet-Gaudelus I, Lesne-Hulin A, Lenoir G, Singlas E, Berche P, Hennequin C. Sputum itraconazole concentrations in cystic fibrosis patients. Antimicrob Agents Chemoter 2001; 45: 1937-8.
  58. Hanley-Lopez J, Clement LT. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med 2000; 6: 540-4.
  59. Murali PS, Greenberger PA, Kurup VP. Cytokines in Allergic Bronchopulmonary Aspergillosis. Immunology and Allergy Clinics of North America 1998; 18 (3): 681-94
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
  Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia

Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Inicio/Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008